The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei
- 31 July 1992
- journal article
- Published by Elsevier in Molecular and Biochemical Parasitology
- Vol. 53 (1-2), 223-231
- https://doi.org/10.1016/0166-6851(92)90024-e
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Subcellular localisation of dihydrolipoamide dehydrogenase and detection of lipoic acid in bloodstream forms of Trypanosoma bruceiEuropean Journal of Biochemistry, 1990
- Purification of a new dihydrolipoamide dehydrogenase from Escherichia coliJournal of Bacteriology, 1989
- Novel biochemical pathways in parasitic protozoaParasitology, 1989
- Trypanothione: A Novel Bis(glutathionyl)spermidine Cofactor for Glutathione Reductase in TrypanosomatidsScience, 1985
- Inhibition of pyruvate dehydrogenase multienzyme complex from Escherichia coli with mono- and bifunctional arsenoxidesBiochemistry, 1978
- A note on the molar absorptivity of reduced Ellman's reagent, 3-carboxylato-4-nitrothiophenolateAnalytical Biochemistry, 1973
- Separation of Trypanosomes from the Blood of Infected Rats and Mice by Anion-exchangersNature, 1968
- Mel B in the Treatment of Human TrypanosomiasisThe American Journal of Tropical Medicine, 1949
- British anti-lewisiteBiochemical Journal, 1946
- On the Mechanism of the Action of Arsenic upon ProtoplasmPublic Health Reports (1896-1970), 1923